Vnitr Lek 2026, 72(1):22-28 | DOI: 10.36290/vnl.2026.003

Gut microbiome in internal medicine

Zdeněk Lys1, 2, Lukáš Štos2, David Galis2, Veronika Janošcová2, Jan Václavík1, 2
1 Interní a kardiologická klinika FN Ostrava
2 Lékařská fakulta, Ostravská univerzita

The gut microbiome is a dynamic ecosystem with many physiological tasks not only in the gut itself, but also in interaction with the immune, endocrine, and nervous systems, as well as in the complex functioning of the organism. Knowledge of the role of the microbiome in the pathophysiology of diseases is growing across the entire spectrum of internal medicine. Knowledge of the role of the microbiome and its metabolites in the context of genetic and epigenetic factors may play a significant role in the diagnosis and treatment of several diseases. Despite many obstacles to clarifying the role of the microbiome, such as high inter- and intra-individual variability and the number of factors involved in interactions, specific information with a potential impact on clinical practice is emerging. In addition to diagnostics, this also includes the prediction of responses to existing treatments or, conversely, the reciprocal effect of commonly used medications on the gut microbiome. In this review article, we attempt to highlight important and potentially practical findings in this area in the field of internal medicine.

Keywords: microbiome, probiotics, fecal bacteriotherapy, metabolites.

Accepted: February 3, 2026; Published: February 12, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lys Z, Štos L, Galis D, Janošcová V, Václavík J. Gut microbiome in internal medicine. Vnitr Lek. 2026;72(1):22-28. doi: 10.36290/vnl.2026.003.
Download citation

References

  1. Turnbaugh PJ, Ley RE, Gordon JI, et al. The Human Microbiome Project. Nature. 2007;449(7164):804-810. [Internet]. 2007 Oct 17 [cited 2025 Dec 7]. Available from: https://www.nature.com/articles/nature06244. Go to original source... Go to PubMed...
  2. Analýza mikrobiomu - úvod do problematiky. [Internet]. [cited 2025 Dec 7]. Available from: https://www.mikrobiom-cms.cz/stanoviska-cms/analyza-mikrobiomu-uvod-do-problematiky/.
  3. Berg G, Rybakova D, Charles T, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. [Internet]. 2020 Jun 30 [cited 2025 Dec 7]. Available from: https://link.springer.com/article/10.1186/s40168-020-00875-0. Go to original source...
  4. Stojanov S, Berlec A, Štrukelj B. The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease. Microorganisms. 2020;8(11):1715. [Internet]. 2020 Nov 1 [cited 2025 Dec 7]. Available from: https://www.mdpi.com/2076-2607/8/11/1715/htm. Go to original source... Go to PubMed...
  5. Van Hul M, Cani PD, El-Omar EM, et al. What defines a healthy gut microbiome? Gut. 2024;73(11):1893-1908. [Internet]. 2024 Nov 1 [cited 2025 Dec 8]. Available from: https://gut.bmj.com/content/73/11/1893. Go to original source... Go to PubMed...
  6. Meng Y, Wu F, Freedman ND, et al. Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. JAMA Oncol. 2025;11(11):1331-1340. [Internet]. 2025 Nov 1 [cited 2025 Dec 7]. Available from: https://jamanetwork.com/journals/jamaoncology/fullarticle/2839132. Go to original source... Go to PubMed...
  7. Guo X, Li J, Nie Y, et al. Gut microbiota and epigenetic inheritance: implications for the development of IBD. Gut Microbes. 2025;17(1). [Internet]. 2025 Dec 31 [cited 2025 Dec 7]. Available from: https://www.tandfonline.com/doi/abs/10.1080/19490976.2025.2490207. Go to original source... Go to PubMed...
  8. Yaqub MO, Jain A, Edison LK, et al. Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine. Gastrointest Disord. 2025;7(1):7. [Internet]. 2025 Jan 15 [cited 2025 Dec 8]. Available from: https://www.mdpi.com/2624-5647/7/1/7/htm. Go to original source...
  9. Porcari S, Ng SC, Elinav E, et al. The microbiome for clinicians. Cell. 2025;188(11):2836-2844. [Internet]. 2025 May 29 [cited 2025 Dec 8]. Available from: https://www.cell.com/action/showFullText?pii=S0092867425004489. Go to original source... Go to PubMed...
  10. Kondapalli N, Katari V, Thodeti CK, et al. Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease. Compr Physiol. 2025;15(3):e70024. Go to original source... Go to PubMed...
  11. Tuteja S, Ferguson JF. Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019;12(9):421-429. Go to original source... Go to PubMed...
  12. Xu J, Moore BN, Pluznick JL. Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021. Hypertension. 2022;79(10):2127-2137. Go to original source... Go to PubMed...
  13. Schiattarella GG, Sannino A, Franzone A, et al. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J. 2017;38(39):2948-2956. Go to original source... Go to PubMed...
  14. Tang WHW, Wang Z, Fu X, et al. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk. N Engl J Med. 2013;368(17):1575-1584. Go to original source... Go to PubMed...
  15. Nesci A, Carnuccio C, Santoro L, et al. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship. Int J Mol Sci. 2023;24(10):9087. [Internet]. 2023 May 1 [cited 2026 Jan 21]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10219307/. Go to original source... Go to PubMed...
  16. Ullah H, Arbab S, Rehman SU, et al. Gut microbiota therapy in gastrointestinal diseases. Front Cell Dev Biol. 2025;13:1514636. Go to original source... Go to PubMed...
  17. Hu KA, Gubatan J. Gut microbiome-based therapeutics in inflammatory bowel disease. Clin Transl Discov. 2023;3(2):e182. [Internet]. 2023 Apr 1 [cited 2025 Dec 7]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/ctd2.182. Go to original source...
  18. Ha S, Wong VWS, Zhang X, Yu J. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2025;74(1):141-152. [Internet]. 2025 Jan 1 [cited 2025 Dec 7]. Available from: https://gut.bmj.com/content/74/1/141. Go to original source... Go to PubMed...
  19. Laiola M, Koppe L, Quinquis B, et al. Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study. Gut. 2025;74(10):1624-1637. [Internet]. 2025 Oct 1 [cited 2025 Dec 7]. Available from: https://gut.bmj.com/content/74/10/1624. Go to original source... Go to PubMed...
  20. Li HB, Xu ML, Li L, et al. Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis. Circ Res. 2022;131(9):E120-E134. [Internet]. 2022 Oct 14 [cited 2025 Dec 7]. Available from: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.122.320184. Go to original source... Go to PubMed...
  21. Feng Z, Zhang Y, Chen D, et al. Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study. Front Immunol. 2023;14:1277554. [Internet]. 2023 Jan 12 [cited 2025 Dec 7]. Available from: https://gwas.mrcieu.ac.uk/. Go to original source... Go to PubMed...
  22. Kim MG, Cho WY, Park MS, et al. Altered gut microbiome plays an important role in AKI to CKD transition in aged mice. Front Med (Lausanne). 2023;10:1238960. [Internet]. 2023 Oct 31 [cited 2025 Dec 7]. Available from: http://www.bio-protocol.org/e1289. Go to original source... Go to PubMed...
  23. Holle J, Reitmeir R, Potapenko O, et al. Gut microbiome alterations precede graft rejection in kidney transplantation patients. Am J Transplant. 2025;25(8):1643-1656. Go to original source... Go to PubMed...
  24. Kim YC, Sohn KH, Kang HR. Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches. Korean J Intern Med. 2024;39(5):746. Go to original source... Go to PubMed...
  25. Tanevska E, Leyton CE, Seamark R. The usefulness of microbiome profiling for geriatric patients with neuropsychiatric conditions: a scoping review. Transl Psychiatry. 2025;15(1):420. Go to original source... Go to PubMed...
  26. Seo D oh, Holtzman DM. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies. Exp Mol Med. 2024;56(1):86-94. Go to original source... Go to PubMed...
  27. Eyting M, Xie M, Geldsetzer P, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-446. Go to original source... Go to PubMed...
  28. Fliegerová KO, Mahayri TM, Jarošíková R, et al. Diabetes and gut microbiome. Front Microbiol. 2024;15:1451054. Go to original source... Go to PubMed...
  29. Deng X, Zhang C, Wang P, et al. Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes. J Clin Endocrinol Metab. 2022;107(7):1888-1896. [Internet]. 2022 Jun 16 [cited 2025 Dec 7]. Available from: https://dx.doi.org/10.1210/clinem/dgac210. Go to original source... Go to PubMed...
  30. Shaheen WA, Quraishi MN, Iqbal TH. Gut microbiome and autoimmune disorders. Clin Exp Immunol. 2022;209(2):161-174. [Internet]. 2022 Aug 19 [cited 2025 Dec 8]. Available from: https://dx.doi.org/10.1093/cei/uxac057. Go to original source... Go to PubMed...
  31. Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol. 2023;19(8):460-476. [Internet]. 2023 May 2 [cited 2025 Dec 7]. Available from: https://www.nature.com/articles/s41574-023-00833-4. Go to original source... Go to PubMed...
  32. Routy B, Le Chatelier E, Daillère R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91-97. [Internet]. 2018 Jan 5 [cited 2025 Dec 7]. Available from: https://www.science.org/doi/10.1126/science.aan3706. Go to original source... Go to PubMed...
  33. Kumar A, Sun R, Palm NW, et al. Identification of medication-microbiome interactions that affect gut infection. Nature. 2025;644(8076):506-515. [Internet]. 2025 Jul 16 [cited 2025 Dec 7]. Available from: https://www.nature.com/articles/s41586-025-09273-8. Go to original source... Go to PubMed...
  34. Aasmets O, Taba N, Metspalu M, et al. A hidden confounder for microbiome studies: medications used years before sample collection. mSystems. 2025;???. [Internet]. 2025 Oct 22 [cited 2025 Dec 7]. Available from: https://journals.asm.org/doi/10.1128/msystems.00541-2.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.